Emibetuzumab (Anti-HGFR / c-Met)
Emibetuzumab (Anti-HGFR / c-Met) is a humanized bivalent MET antibody targeting both HGF-dependent and HGF-independent MET pathway activation and tumor growth. It can be used in study of cancer. MW :144.56 KD.
| Trivial name | LY2875358 |
| Catalog Number | A2662 |
| CAS# | 1365287-97-3 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/emibetuzumab.html |